Brain implants that deliver electric pulses can ease depression in people who aren’t responding to psychiatric drugs, a new study says.
Half of a small group of people who received brain implants experienced significant improvement in their…

Brain implants that deliver electric pulses can ease depression in people who aren’t responding to psychiatric drugs, a new study says.
Half of a small group of people who received brain implants experienced significant improvement in their…

A previously unknown type of DNA damage in the mitochondria, the tiny power plants inside our cells, could shed light on how our bodies sense and respond to stress. The findings of the UC Riverside-led study are published today in the Proceedings…

An international randomized clinical trial has shown that closed-loop insulin delivery improves glycemic control during pregnancy for individuals with type 1 diabetes, according to findings published in JAMA and summarized in a new announcement…

Jennifer Munson, a cancer researcher at Virginia Tech’s Fralin Biomedical Research Institute at VTC, has been awarded two new National Institutes of Health grants to advance greater understanding and improved treatment of a deadly…

A recently published

Measles is making a troubling comeback worldwide, and the United States may lose its status as a country that has eliminated the disease. In the last 5 years, new cases have been reported in more than 100 countries.¹ As per the CDC, the total…

Eating moderate amounts of lean beef as part of a Mediterranean diet does not increase an emerging risk factor for cardiovascular disease, according to a new study by an interdisciplinary research team at Penn State. The researchers…

By The ASCO Post Staff
Posted: 11/19/2025 11:00:00 AM
Last Updated:
Curative treatment following first-line immunotherapy is infrequently received, but when it was utilized, it significantly…

By Matthew Stenger
Posted: 11/19/2025 9:30:00 AM
Last Updated:
As reported in the The New England Journal of Medicine by Kunkler et al, the phase III SUPREMO trial showed no significant difference in…

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small fraction of patients. Many tumors develop resistance or evade immune detection through genetic and…